NC
Nexthera Capital Portfolio holdings
AUM
$120M
This Quarter Return
-12.63%
1 Year Return
+20.18%
3 Year Return
+117.79%
5 Year Return
–
10 Year Return
–
AUM
$152M
AUM Growth
+$152M
(-59%)
Cap. Flow
-$183M
Cap. Flow
% of AUM
-120.53%
Top 10 Holdings %
Top 10 Hldgs %
85.9%
Holding
59
New
4
Increased
8
Reduced
7
Closed
34
Top Buys
| 1 |
Novartis
NVS
|
$27.1M |
| 2 |
Heron Therapeutics
HRTX
|
$18.9M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$7.74M |
| 4 |
Insmed
INSM
|
$4.92M |
| 5 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
$4.75M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
$30.2M |
| 2 |
Exelixis
EXEL
|
$28.1M |
| 3 |
Viatris
VTRS
|
$25.5M |
| 4 |
DOVA
Dova Pharmaceuticals, Inc. Common Stock
DOVA
|
$21.5M |
| 5 |
TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
|
$17.7M |
Sector Composition
| 1 | Healthcare | 91.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Novartis
NVS
$245B
| $27.1M | 11.18% | +316,117 | New | +$27.1M |
|
|
2
Heron Therapeutics
HRTX
$207M
| $21.2M | 8.76% | 819,164 +729,315 | +812% | +$18.9M |
|
|
BOLD
3
DELISTED
Audentes Therapeutics, Inc
BOLD
| $16.3M | 6.72% | 764,193 +223,021 | +41% | +$4.75M |
|
|
IMMU
4
DELISTED
Immunomedics Inc
IMMU
| $12.8M | 5.26% | 894,679 -503,898 | -36% | -$7.19M |
|
5
Bausch Health
BHC
$2.74B
| $12.3M | 5.06% | 664,837 +119,337 | +22% | +$2.2M |
|
|
6
Insmed
INSM
$28.8B
| $11M | 4.54% | 838,946 +374,787 | +81% | +$4.92M |
|
|
GBT
7
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $9.1M | 3.75% | 221,662 -327,569 | -60% | -$13.4M |
|
|
HZNP
8
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $7.74M | 3.19% | +396,198 | New | +$7.74M |
|
|
STML
9
DELISTED
Stemline Therapeutics, Inc.
STML
| $6.76M | 2.79% | 711,558 +129,488 | +22% | +$1.23M |
|
|
10
Exelixis
EXEL
$10.1B
| $6.05M | 2.49% | 307,739 -1,427,291 | -82% | -$28.1M |
|
|
CBAY
11
DELISTED
Cymabay Therapeutics
CBAY
| $5.63M | 2.32% | 714,764 -193,900 | -21% | -$1.53M |
|
|
CHMA
12
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $3.32M | 1.37% | 1,066,439 +429,793 | +68% | +$1.34M |
|
13
Gyre Therapeutics
GYRE
$703M
| $2.97M | 1.22% | 376,010 -516,569 | -58% | -$4.08M |
|
|
DCPH
14
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $2.56M | 1.05% | 121,892 +91,270 | +298% | +$1.92M |
|
15
Sutro Biopharma
STRO
$72.7M
| $2.25M | 0.93% | 249,496 +17,883 | +8% | +$161K |
|
|
ZSAN
16
DELISTED
Zosano Pharma Corporation
ZSAN
| $1.69M | 0.7% | 798,719 -235,040 | -23% | -$498K |
|
|
ATNX
17
DELISTED
Athenex, Inc. Common Stock
ATNX
| $1.57M | 0.65% | +123,305 | New | +$1.57M |
|
|
RVLP
18
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $935K | 0.39% | +120,620 | New | +$935K |
|
19
MediWound
MDWD
$182M
| $424K | 0.17% | 104,546 -68,530 | -40% | -$278K |
|
|
VCNX
20
DELISTED
Vaccinex, Inc. Common Stock
VCNX
| $62K | 0.03% | 17,047 | – | – |
|
21
Abeona Therapeutics
ABEO
$350M
| – | – | -849,979 | Closed | -$10.9M |
|
22
Acadia Pharmaceuticals
ACAD
$4.38B
| – | – | -43,980 | Closed | -$913K |
|
|
ADAP
23
Adaptimmune Therapeutics
ADAP
$15.6M
| – | – | -74,132 | Closed | -$1.01M |
|
24
AstraZeneca
AZN
$248B
| – | – | -193,279 | Closed | -$7.65M |
|
25
BioMarin Pharmaceuticals
BMRN
$11.2B
| – | – | 0 | – | – |
|